Works about MITOXANTRONE
Results: 317
Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 3, p. 252, doi. 10.1111/vco.12092
- By:
- Publication type:
- Article
Dynamic and Assembly Characteristics of Deep‐Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic Systems.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 68, p. 1, doi. 10.1002/chem.202303374
- By:
- Publication type:
- Article
Characterization of Novel Non-Synonymous Genomic Variants Altering Drug Response of DNA Topoisomerase II Alpha.
- Published in:
- International Journal of Cancer Management, 2019, v. 12, n. 4, p. 1, doi. 10.5812/ijcm.66993
- By:
- Publication type:
- Article
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro.
- Published in:
- Cell Discovery, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41421-020-00222-5
- By:
- Publication type:
- Article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Bazı Kemoterapötik İlaçların İnsan Serumu Paraoksonaz-1 (PON1) Üzerindeki İnhibisyon Etkisinin Araştırılması.
- Published in:
- Journal of the Institute of Science & Technology / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2022, v. 12, n. 1, p. 297, doi. 10.978179/jist.978179
- By:
- Publication type:
- Article
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 921, doi. 10.3390/biom13060921
- By:
- Publication type:
- Article
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00208
- By:
- Publication type:
- Article
Combinatorial strategies for the induction of immunogenic cell death.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00187
- By:
- Publication type:
- Article
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 488, doi. 10.1038/bmt.2011.109
- By:
- Publication type:
- Article
Corrigendum to ‘Multiple sclerosis: New insights and trends’.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Multiple sclerosis: New insights and trends.
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2016, v. 6, n. 5, p. 429, doi. 10.1016/j.apjtb.2016.03.009
- By:
- Publication type:
- Article
In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 677, doi. 10.1007/s13402-018-0400-x
- By:
- Publication type:
- Article
Effect of Dose Ratio on Mitoxantrone and Daunorubicin in Acute Myeloid Leukemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In vivo evaluation of Sono-chemo therapy via hollow gold nanoshells conjugated to mitoxantrone on breast cancer.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2023, v. 26, n. 3, p. 285, doi. 10.22038/IJBMS.2023.67602.14811
- By:
- Publication type:
- Article
Clinical Efficacy of Mitoxantrone and Ara-C with or without Etoposide Salvage Chemotherapy in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Retrospective Multicenter Study of the Korean Adult ALL Working Party.
- Published in:
- Acta Haematologica, 2014, v. 133, n. 1, p. 91, doi. 10.1159/000362261
- By:
- Publication type:
- Article
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression.
- Published in:
- BMC Research Notes, 2014, v. 7, p. 1, doi. 10.1186/1756-0500-7-710
- By:
- Publication type:
- Article
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic Arthritis.
- Published in:
- Journal of Rheumatology, 2021, v. 48, n. 10, p. 1547, doi. 10.3899/jrheum.210175
- By:
- Publication type:
- Article
Do we still need morphologic evaluation in new era of advanced minimal residual disease analyses?
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 6, p. e145, doi. 10.1111/ijlh.13045
- By:
- Publication type:
- Article
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 4, p. 557, doi. 10.1007/s00277-014-2242-6
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.
- Published in:
- 2007
- By:
- Publication type:
- journal article
T-cell acute lymphoblastic leukemia with involvement of extramedullary sites, including the pericardium.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2025, v. 83, n. 1, p. 83, doi. 10.33963/v.phj.102552
- By:
- Publication type:
- Article
Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first-line induction therapy for newly diagnosed multiple myeloma in a single institution of China.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e408, doi. 10.1111/ajco.12609
- By:
- Publication type:
- Article
Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote mitoxantrone resistance in stomach adenocarcinoma.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-023-08933-0
- By:
- Publication type:
- Article
In Vitro L6 Irritation Assay Predicts Clinical Injection Site Reactions for Small Molecules.
- Published in:
- Toxicological Sciences, 2016, v. 151, n. 2, p. 302, doi. 10.1093/toxsci/kfw050
- By:
- Publication type:
- Article
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 536, doi. 10.3390/jcm9020536
- By:
- Publication type:
- Article
Cumulative Mitoxantrone-Induced Haematological and Hepatic Adverse Effects in a Subchronic In vivo Study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2014, v. 114, n. 3, p. 254, doi. 10.1111/bcpt.12143
- By:
- Publication type:
- Article
Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus.
- Published in:
- Biomedicines, 2021, v. 9, n. 9, p. 1176, doi. 10.3390/biomedicines9091176
- By:
- Publication type:
- Article
A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60689-w
- By:
- Publication type:
- Article
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
- Published in:
- ISRN Neurology, 2013, p. 1, doi. 10.1155/2013/748127
- By:
- Publication type:
- Article
Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors**.
- Published in:
- Molecular Informatics, 2024, v. 43, n. 3, p. 1, doi. 10.1002/minf.202300284
- By:
- Publication type:
- Article
Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
- Published in:
- Nanotoxicology, 2016, v. 10, n. 5, p. 557, doi. 10.3109/17435390.2015.1095364
- By:
- Publication type:
- Article
Comparison of Mitoxantrone versus Cyclophosphamide Treatment in Patients with Secondary Progressive Multiple Sclerosis.
- Published in:
- Dicle Medical Journal / Dicle Tip Dergisi, 2022, v. 49, n. 1, p. 29, doi. 10.5798/dicletip.1086113
- By:
- Publication type:
- Article
Adult‐onset Rasmussen encephalitis treated with mitoxantrone.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Where mitoxantrone for multiple sclerosis is still valuable in 2018.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Clinical follow‐up of 411 patients with relapsing and progressive multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real‐life cohort study.
- Published in:
- European Journal of Neurology, 2018, v. 25, n. 12, p. 1439, doi. 10.1111/ene.13748
- By:
- Publication type:
- Article
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment.
- Published in:
- European Journal of Neurology, 2018, v. 25, n. 8, p. 1063, doi. 10.1111/ene.13650
- By:
- Publication type:
- Article
Deep eutectic solvent-doped graphite as an efficient adsorbent for pipette tip micro-solid phase extraction of mitoxantrone from seawater, drug, urine and blood samples prior to its spectrophotometric determination.
- Published in:
- Journal of the Iranian Chemical Society, 2024, v. 21, n. 3, p. 689, doi. 10.1007/s13738-023-02951-2
- By:
- Publication type:
- Article
Retrospective Study of Adverse Events of Chemotherapy in Cats.
- Published in:
- Acta Scientiae Veterinariae, 2018, v. 46, p. 1, doi. 10.22456/1679-9216.81801
- By:
- Publication type:
- Article
Effect of mitoxantrone on proliferation dynamics and cell-cycle progression.
- Published in:
- Bioscience Reports, 2010, v. 30, n. 6, p. 375, doi. 10.1042/BSR20090119
- By:
- Publication type:
- Article
Inhibition of transcription factor assembly and structural stability on mitoxantrone binding with DNA.
- Published in:
- Bioscience Reports, 2010, v. 30, n. 5, p. 331, doi. 10.1042/BSR20090083
- By:
- Publication type:
- Article
A Case of Marburg's Variant of Multiple Sclerosis Successfully Treated with IVIg and Mitoxantrone.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Multiple sclerosis in India.
- Published in:
- Annals of Indian Academy of Neurology, 2018, v. 21, n. 2, p. 95, doi. 10.4103/aian.AIAN_296_18
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- Case Study